Affiliation:
1. Department of Medical Microbiology, St. Radboud Hospital, University of Nijmegen, The Netherlands.
Abstract
BAY Y3118 was highly active against Moraxella catarrhalis, Haemophilus influenzae, Legionella pneumophila, Escherichia coli, Klebsiella pneumoniae, Staphylococcus aureus (except quinolone-resistant, methicillin-resistant S. aureus), Staphylococcus epidermidis, Streptococcus pyogenes, Streptococcus agalactiae, and Streptococcus pneumoniae (MIC for 90% of strains tested [MIC90], 0.063 micrograms/ml). For Enterococcus faecalis and Corynebacterium jeikeium, MIC90s were 4 and 2 micrograms/ml, respectively. BAY Y3118 was as active as ciprofloxacin against Pseudomonas aeruginosa (MIC90, 0.5 micrograms/ml) and had potent activity against Bacteroides fragilis (MIC90, 0.5 micrograms/ml).
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology
Reference11 articles.
1. Rapid development of ciprofloxacin resistance in methicillin-susceptible and methicillin-resistant Staphylococcus aureus;Blumberg H. M.;J. Infect. Dis.,1991
2. Comparative activity of ciprofloxacin, ofloxacin, sparfloxacin, temafloxacin, CI-960, CI-990, and WIN 57273 against anaerobic bacteria;Goldstein E. J. C.;Antimicrob. Agents Chemother.,1992
3. Comparative in vitro activity of five quinoline derivatives and five other antimicrobial agents used in oral therapy;Hoogkamp-Korstanje J. A. A.;Eur. J. Clin. Microbiol.,1984
4. In vitro and in vivo activity of five fluoroquinolones against common pathogens;Hoogkamp-Korstanje J. A. A.;J. Drug Dev.,1989
5. National Committee for Clinical Laboratory Standards. 1990. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically 2nd ed. Approved standard M7-A2. National Committee for Clinical Laboratory Standards Villanova Pa.
Cited by
21 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献